A detailed history of Israel Englander (Millennium Management LLC) transactions in Alvotech stock. As of the latest transaction made, Millennium Management LLC holds 126,475 shares of ALVO stock, worth $1.53 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
126,475
Previous 116,018 9.01%
Holding current value
$1.53 Million
Previous $1.41 Million 6.74%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$10.76 - $12.99 $112,517 - $135,836
10,457 Added 9.01%
126,475 $1.51 Million
Q2 2024

Aug 14, 2024

BUY
$11.4 - $14.51 $1.32 Million - $1.68 Million
116,018 New
116,018 $1.41 Million

Others Institutions Holding ALVO

About Alvotech


  • Ticker ALVO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 248,650,000
  • Market Cap $3.01B
  • Description
  • Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...
More about ALVO
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.